ATHX - Athersys, Inc.
2.02 0.00 (0.00%)
After hours: 4:45PM EDT
| Previous Close | 2.02 |
| Open | 2.00 |
| Bid | 1.91 x 2700 |
| Ask | 2.20 x 6700 |
| Day's Range | 1.92 - 2.05 |
| 52 Week Range | 1.29 - 2.63 |
| Volume | 456,472 |
| Avg. Volume | 619,779 |
| Market Cap | 278.417M |
| Beta | -0.42 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.29 |
| Earnings Date | May 10, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.33 |
- GlobeNewswire•8 days ago
Athersys to Host First Quarter Financial Results Call
CLEVELAND, April 12, 2018-- Athersys, Inc. will release its first quarter 2018 financial results at approximately 4:00 PM Eastern Time on Thursday, May 10, 2018, and will host a conference call shortly ...
- Thomson Reuters StreetEvents•10 days ago
Edited Transcript of ATHX conference call or presentation 28-Jul-10 8:30pm GMT
Athersys to Host Conference Call to Announce Phase I Clinical Trial Results Involving MultiStem(R) for Acute Myocardial Infarction
- Simply Wall St.•21 days ago
Best Growth Stock in March
Companies such as inTEST and Energy Recovery have a significantly positive future outlook on the basis of their profitability and returns. Investors seeking to enhance their portfolio should consider theseRead More...
- ACCESSWIRE•26 days ago
Wired News – Reata Pharma Reports Positive Top-line Data from its Phase-2 LARIAT Trial
Stock Monitor: Athersys Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 26, 2018 / Active-Investors.com has just released a free research report on Reata Pharmaceuticals, Inc. (NASDAQ: RETA ). ...
- GlobeNewswire•last month
Athersys to Present at Needham Healthcare Conference on March 28
CLEVELAND, March 20, 2018-- Athersys, Inc. announced today that Gil Van Bokkelen, Chairman and CEO, will present a corporate overview at the 17 th Annual Needham Healthcare Conference at The Westin Grand ...
- Thomson Reuters StreetEvents•last month
Edited Transcript of ATHX earnings conference call or presentation 13-Mar-18 8:30pm GMT
Q4 2017 Athersys Inc Earnings Call
- GlobeNewswire•last month
Athersys Reports Financial Results for Fourth Quarter, Full Year 2017
Company also announces equity investment and binding letter of intent to expand HEALIOS K.K. collaboration, covered in a separate release. Management to host conference call at 4:30 PM EDT today. CLEVELAND, ...
- ACCESSWIRE•last month
Athersys, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / March 13, 2018 / Athersys, Inc. (NASDAQ: ATHX ) will be discussing their earnings results in their Q4 Earnings Call to be held on March 13, 2018, at 4:30 PM Eastern Time. To ...
- Benzinga•last month
Benzinga Pro's 5 Stock To Watch Today
Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user ! Athersys, Inc. (NASDAQ: ATHX ) stock gained more than ...
- GlobeNewswire•last month
Athersys and HEALIOS Announce Binding Letter of Intent to Expand MultiStem® Collaboration
Equity investment and binding letter of intent outlines expansion of Japan collaboration, including exclusive option for China development and commercialization. Benefits to include consolidated development ...
- GlobeNewswire•last month
Athersys and Healios Announce Binding Letter of Intent to Expand MultiStem® Collaboration
Equity investment and binding letter of intent outlines expansion of Japan collaboration, including exclusive option for China development and commercialization Benefits to include consolidated development ...
- GlobeNewswire•2 months ago
Report: Exploring Fundamental Drivers Behind BWX Technologies, WMIH, Conn's, Athersys, Proofpoint, and Kindred Healthcare — New Horizons, Emerging Trends, and Upcoming Developments
NEW YORK, March 01, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
- GlobeNewswire•2 months ago
Athersys to Host Year-End 2017 Financial Results Call
CLEVELAND, Feb. 12, 2018-- Athersys, Inc. will release its year-end 2017 financial results at approximately 4:00 PM Eastern Time on Tuesday, March 13, 2018, and will host a conference call shortly thereafter ...
- GlobeNewswire•3 months ago
Athersys Enters Into New $100 Million Equity Facility with Aspire Capital
Provides access to capital to support ongoing business and development objectives. CLEVELAND, Feb. 02, 2018-- Athersys, Inc. and Aspire Capital Fund, LLC announced today that a new equity facility has ...
- GlobeNewswire•3 months ago
Athersys CEO to Speak at the 2018 Brain Health Summit
CLEVELAND, Ohio, Jan. 29, 2018-- Athersys, Inc. announced today that Gil Van Bokkelen, Chairman and CEO, will be a speaker and panelist at the 2018 Brain Health Summit organized by the Brain Treatment ...
- Reuters•4 months ago
Tiny stem cell companies close in on major heart disease goals
The early hope that stem cell therapy would make the paralyzed walk, the blind see and cure diabetes have given way to a long list of failures, highlighted by early stem cell champion Geron Corp abandoning the field in 2011. Both have overcome major hurdles to manufacturing stem cell treatments on a large scale that are off-the-shelf products derived from healthy donor bone marrow and do not face immune system rejection issues. Cleveland-based Athersys, with a market value of about $200 million, demonstrated evidence in a midstage trial that its therapy may be able to expand the emergency treatment window for major strokes to up to 36 hours, compared with about four hours with current drugs, potentially allowing many more patients to avoid crippling disabilities.
- Thomson Reuters StreetEvents•5 months ago
Edited Transcript of ATHX earnings conference call or presentation 8-Nov-17 9:30pm GMT
Q3 2017 Athersys Inc Earnings Call
- ACCESSWIRE•5 months ago
Athersys, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / November 8, 2017 / Athersys, Inc. (NASDAQ: ATHX ) will be discussing their earnings results in their Q3 Earnings Call to be held on November 8, 2017 at 4:30 PM Eastern Time. ...
- ACCESSWIRE•6 months ago
Featured Company News - Athersys Signs Agreement with Nikon CeLL Innovation for Commercial Manufacturing of MultiStem in Japan
LONDON, UK / ACCESSWIRE / October 13, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Athersys, Inc. (NASDAQ: ATHX ), following which we have published ...
- Zacks•6 months ago
Athersys (ATHX) in Focus: Stock Moves 7.2% Higher
Athersys (ATHX) shares rose more than 7% in the last trading session, amid huge volumes.
- ACCESSWIRE•6 months ago
Today's Research Reports on Trending Tickers: Athersys and Pluristem Therapeutics
NEW YORK, NY / ACCESSWIRE / October 12, 2017 / All three major indexes closed at record highs Wednesday after minutes from the most recent Federal Reserve Meeting suggested a December rate hike was not ...
